Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma
Journal
European journal of nuclear medicine and molecular imaging
Journal Volume
47
Journal Issue
8
Date Issued
2020
Author(s)
Ferrone, Cristina
Goyal, Lipika
Qadan, Motaz
Gervais, Debra
Sahani, Dushyant V
Zhu, Andrew X
Hong, Theodore S
Blaszkowsky, Lawrence S
Tanabe, Kenneth K
Vangel, Mark
Amorim, Barbara J
Wo, Jennifer Y
Mahmood, Umar
Pandharipande, Pari V
Catana, Ciprian
Duenas, Virginia P
Collazo, Yolanda Q
Canamaque, Lina G
Domachevsky, Liran
Bernstine, Hanna H
Groshar, David
Li, Yan
Herrmann, Ken
Umutlu, Lale
Rosen, Bruce R
Catalano, Onofrio A
Abstract
Intrahepatic cholangiocarcinoma (ICC) is associated with a poor prognosis with surgical resection offering the best chance for long-term survival and potential cure. However, in up to 36% of patients who undergo surgery, more extensive disease is found at time of operation requiring cancellation of surgery. PET/MR is a novel hybrid technology that might improve local and whole-body staging in ICC patients, potentially influencing clinical management. This study was aimed to investigate the possible management implications of PET/MR, relative to conventional imaging, in patients affected by untreated intrahepatic cholangiocarcinoma.
Subjects
Cholangiocarcinoma; Clinical management; PET/MR; Staging
SDGs
Other Subjects
antineoplastic agent; fluorodeoxyglucose f 18; gadolinium pentetate meglumine; gadoterate meglumine; fluorodeoxyglucose f 18; radiopharmaceutical agent; adult; advanced cancer; aged; Article; bile duct carcinoma; cancer chemotherapy; cancer radiotherapy; cancer surgery; clinical article; clinical feature; diaphragm; early cancer; female; follow up; human; inferior cava vein; inoperable cancer; laparoscopy; male; McNemar test; nuclear magnetic resonance imaging; peritoneum metastasis; positron emission tomography; positron emission tomography-computed tomography; retrospective study; bile duct cancer; bile duct carcinoma; cancer staging; diagnostic imaging; middle aged; nuclear magnetic resonance imaging; nuclear magnetic resonance spectroscopy; pathology; positron emission tomography; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies
Type
journal article